… Although there is information on the effects of rivaroxaban and apixaban on the … to apixaban
but sensitive to rivaroxaban 2 . To confirm these findings, we added apixaban or rivaroxaban …

… screening tests: the prothrombin times (PT) or activated partial thromboplastin time (APTT), …
of commonly used PT and APTT reagents to rivaroxaban, apixaban, and edoxaban, (ii) to …

… , relative to baseline, on inhibition of prothrombin time and activated partial thromboplastin
time. (A) Prothrombin time and (B) Activated partial thromboplastin time. Data are presented …

… However, with apixaban, after an initial decrease, ETP did not differ … apixaban 112 ng/mL,
p = 0.005). In conclusion, due to different dosing and pharmacology rivaroxaban and apixaban …

… given apixaban and rivaroxaban for various therapeutic reasons. The … time (PT) and activated
partial thromboplastin time (APTT) show better sensitivity with rivaroxaban than apixaban. …

… Samples from patients anticoagulated with either rivaroxaban, apixaban or no anticoagulant
were tested for prothrombin time (PT), activated partial thromboplastin time (APTT), DOAC-…

… Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated
partial thromboplastin times using various reagents. J Thromb Haemost 2014; 12: 1–6. 11. …

… thromboplastin time (aPTT) reagent Actin®, prothrombin time (PT) reagent Thromboplastin C
Plus and thrombin time (… Apixaban, rivaroxaban and dabigatran were synthesized at Bristol–…

… testing of prothrombin time and partial thromboplastin time, but our … The prothrombin time
and partial thromboplastin time were … with rivaroxaban and in no patients’ results with apixaban …

… The activated partial thromboplastin time The activated partial thromboplastin time (aPTT)
is a measure of the activity of the in trinsic pathway of the coagulation cascade. Dabigatran. …